NCT00482755View on ClinicalTrials.gov

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

April 8, 2009

Primary Completion Date

March 15, 2010

Study Completion Date

January 18, 2011

Conditions
Breast Cancer
Interventions
DRUG

sunitinib malate

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

PROCEDURE

needle biopsy

PROCEDURE

neoadjuvant therapy

Trial Locations (2)

V5Z 4E6

British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver

M4N 3M5

Edmond Odette Cancer Centre at Sunnybrook, Toronto

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK